Prosecution Insights
Last updated: April 19, 2026

Sphingotec GmbH

6 pending office actions

Portfolio Summary

6
Total Pending OAs
2
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18148633 TREATMENT OF DEMENTIA OR ALZHEIMER'S AN ANTI-ADRENOMEDULLIN (ADM) ANTIBODY OR AN ANTI-ADRENOMEDULLIN ANTIBODY FRAGMENT SAOUD, CHRISTINE J 1645 Non-Final OA Dec 30, 2022
17986255 METHOD FOR PREDICTING THE RISK OF INCIDENCE OF CHRONIC KIDNEY DISEASE MCCOLLUM, ANDREA K 1674 Non-Final OA Nov 14, 2022
17955765 METHOD FOR PREDICTING THE RISK OF GETTING CANCER OR DIAGNOSING CANCER IN A FEMALE SUBJECT MARCSISIN, ELLEN JEAN 1677 Non-Final OA Sep 29, 2022
17415242 SELENOPROTEIN P IN HEART FAILURE WEBB, WALTER E 1612 Final Rejection Jun 17, 2021
16781226 ADRENOMEDULLIN TO GUIDE THERAPY OF BLOOD PRESSURE DECLINE SAOUD, CHRISTINE J 1645 Final Rejection Feb 04, 2020
16315805 ADRENOMEDULLIN FOR ASSESSING CONGESTION IN A SUBJECT WITH ACUTE HEART FAILURE SAOUD, CHRISTINE J 1645 Non-Final OA Jan 07, 2019

Managing Sphingotec GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month